Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Su

Showing results (1091-1100 of 1,172) with videos related to

Pageof 118
Sort By:
Nature Cancer|May 16, 2025
Sensitizing solid tumors to CAR-mediated cytotoxicity by lipid nanoparticle delivery of synthetic antigensLena Gamboa, Ali H Zamat, Chloé A Thiveaud, et al.
Clinical Epigenetics|October 4, 2024
Epigenomic biomarkers insights in PBMCs for prognostic assessment of ECMO-treated cardiogenic shock patientsYi-Jing Hsiao, Su-Chien Chiang, Chih-Hsien Wang, et al.
Annals of the Academy of Medicine, Singapore|June 21, 2024
Artificial intelligence innovation in healthcare: Relevance of reporting guidelines for clinical translation from bench to bedsideZhen Ling Teo, Ann Kwee, John Cw Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 ExpressionChia-Ying Hsu, Gee-Chen Chang, Yi-Ju Chen, et al.
Biological Psychiatry Global Open Science|November 3, 2022
Low-Dose Augmentation With Buprenorphine for Treatment-Resistant Depression: A Multisite Randomized Controlled Trial With Multimodal Assessment of Target EngagementHyewon H Lee, Daniel M Blumberger, Eric J Lenze, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2013
Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancyWendy W Hwang-Verslues, Po-Hao Chang, Yung-Ming Jeng, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2026
Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindredVincent Malotaux, Vivian Ku, Paula Ospina Lopera, et al.
Oncotarget|October 14, 2015
GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosisJeng-Shou Chang, Chia-Yi Su, Wen-Hsuan Yu, et al.
JAMA|July 30, 2020
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersSebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2019
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitorsChing-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Pageof 118

Showing results (1091-1100 of 1,172) with videos related to

Sort By:
Pageof 118
Nature Cancer|May 16, 2025
Sensitizing solid tumors to CAR-mediated cytotoxicity by lipid nanoparticle delivery of synthetic antigensLena Gamboa, Ali H Zamat, Chloé A Thiveaud, et al.
Clinical Epigenetics|October 4, 2024
Epigenomic biomarkers insights in PBMCs for prognostic assessment of ECMO-treated cardiogenic shock patientsYi-Jing Hsiao, Su-Chien Chiang, Chih-Hsien Wang, et al.
Annals of the Academy of Medicine, Singapore|June 21, 2024
Artificial intelligence innovation in healthcare: Relevance of reporting guidelines for clinical translation from bench to bedsideZhen Ling Teo, Ann Kwee, John Cw Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 ExpressionChia-Ying Hsu, Gee-Chen Chang, Yi-Ju Chen, et al.
Biological Psychiatry Global Open Science|November 3, 2022
Low-Dose Augmentation With Buprenorphine for Treatment-Resistant Depression: A Multisite Randomized Controlled Trial With Multimodal Assessment of Target EngagementHyewon H Lee, Daniel M Blumberger, Eric J Lenze, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2013
Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancyWendy W Hwang-Verslues, Po-Hao Chang, Yung-Ming Jeng, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2026
Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindredVincent Malotaux, Vivian Ku, Paula Ospina Lopera, et al.
Oncotarget|October 14, 2015
GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosisJeng-Shou Chang, Chia-Yi Su, Wen-Hsuan Yu, et al.
JAMA|July 30, 2020
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersSebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2019
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitorsChing-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Pageof 118